ProQR Therapeutics N.V. PRQR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.41% | -63.07% | -58.70% | -81.40% | -85.44% |
| Total Depreciation and Amortization | 8.74% | 6.86% | 2.26% | -2.49% | -1.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 173.25% | 390.36% | 130.71% | 448.10% | 213.98% |
| Change in Net Operating Assets | -127.55% | -8.02% | -36.10% | -11.55% | 47.18% |
| Cash from Operations | -24.95% | -41.19% | -51.02% | -53.33% | -23.44% |
| Capital Expenditure | -66.19% | -14.00% | 24.57% | 66.27% | 61.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -145.27% | 227.51% |
| Cash from Investing | -108.90% | -107.50% | 71.93% | -183.39% | 203.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -25.72% | -4.72% | -20.42% | 40.57% | 39.68% |
| Issuance of Common Stock | -31.43% | -100.00% | -99.90% | 19,084.49% | 13,592.94% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -26.55% | -102.55% | -102.77% | 3,174.19% | 3,438.93% |
| Foreign Exchange rate Adjustments | 137.06% | -570.67% | -309.04% | -170.48% | -2,188.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.50% | -218.33% | -299.70% | 149.61% | 180.31% |